<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BackgroundCD163 is a 130-kDa transmembrane protein expressed in human monocytes and macrophages, and the aberrant expression of CD163 in breast and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> associated with patients' poor prognosis was reported </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we analyzed the expression of CD163 in <z:hpo ids='HP_0002858'>meningioma</z:hpo>, a common <z:e sem="disease" ids="C1527390" disease_type="Neoplastic Process" abbrv="">intracranial tumor</z:e>, and its molecular mechanism in association with <z:hpo ids='HP_0002858'>meningioma</z:hpo> progression.MethodsFirst, we performed immunohistochemical analysis using 50 human <z:hpo ids='HP_0002858'>meningioma</z:hpo> specimens </plain></SENT>
<SENT sid="2" pm="."><plain>Next, we established CD163-overexpressing human <z:hpo ids='HP_0002858'>meningioma</z:hpo> cell lines and investigated its roles in <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> in vitro and in vivo.ResultsImmunohistochemically, 26 of 50 human <z:hpo ids='HP_0002858'>meningioma</z:hpo> specimens (52.0%) were positive for CD163 in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells, including benign grade I (48.5%) and grade II (71.4%) cases </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, CD163 expression was correlated with histological atypical parameters that directly predict the prognosis of <z:hpo ids='HP_0002858'>meningioma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>CD163-overexpressing <z:hpo ids='HP_0002858'>meningioma</z:hpo> cells showed significant suppression of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and accelerated <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> in <z:mp ids='MP_0003815'>nude</z:mp> mice </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, unexpected <z:hpo ids='HP_0001744'>splenomegaly</z:hpo> affiliated with the xenograft predicted <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-derived granulocyte colony-stimulating factor (G-CSF) production, which was confirmed by reverse-transcription polymerase chain reaction and enzyme-linked immunosorbent assay.ConclusionsTo our knowledge, this is the first report that demonstrates CD163 expression in <z:hpo ids='HP_0002858'>meningioma</z:hpo> not only by immunohistochemistry but also by reverse-transcription polymerase chain reaction, using primary culture cells, and provides the novel molecular function of CD163 to prevent <z:mpath ids='MPATH_3'>apoptosis</z:mpath> through the production of G-CSF in <z:hpo ids='HP_0002858'>meningioma</z:hpo> </plain></SENT>
</text></document>